Search

Search results

1. Value for Money from Health Insurance Systems in Canada and the OECD, 2012 edition

   This paper compares the economic performance of Canada's health insurance system against the health insurance systems of 27 other countries that are members of the Organisation for Economic Co-operation and Development (OECD). According to the most ...

2. Access Delayed, Access Denied: Waiting for New Medicines in Canada: 2012

   This edition of Access Delayed, Access Denied is the Fraser Institute?s sixth annual report measuring delays in the approval of new drugs by Health Canada and rates of coverage for new drugs under provincial public drug plans, relative to private-sector ...

3. The Misguided War against Medicines 2011

   Government spending on all types of prescription drugs (patented and non-patented) is increasing faster than any other component of health spending. And new or patented medicines tend to be more expensive compared to older drugs and other health ...

4. Average Personal Affordability of Prescription Drug Spending in Canada and the United States 2011

   The findings of this study suggest that, on average, greater government intervention in Canada?s drug markets has not provided more affordable access to prescription drugs relative to a less interventionist policy in the United States. Much of Canadian ...

5. Access Delayed, Access Denied: Waiting for New Medicines in Canada 2011

   This report focuses on new patented medicines because this class of drugs is uniquely affected by public policies that delay access for patients. Because government approval of generic drugs is based on the assumption that generics are copies of new drugs ...

6. Canada's Medicare Bubble: Is Government Health Spending Sustainable without User-based Funding?

   Canada's Medicare Bubble examines whether the public costs associated with Canada’s health system are economically sustainable. Total provincial health spending has grown at an average annual rate of 7.5% over the last ten years, compared to only 5.7 ...

7. Auto Insurance Market Quality Index 2010

   This study aims to explain the link between the regulation of auto insurance markets and the effect of this regulation on consumers, and to help identify public policies that are most likely to produce superior results. Among the 60 jurisdictions analyzed ...

8. Value for Money from Health Insurance Systems in Canada and the OECD

   This paper compares the economic performance of Canada?s health insurance system against the health insurance systems of 27 other countries that are members of the Organisation for Economic Co-operation and Development (OECD). Economic performance is ...

9. Canada's Drug Price Paradox, 2010

   Since 2005, this study has regulary compared Canadian and American retail prices for an identical group of the 100 most commonly prescribed brand-name (mostly patented) drugs and the 100 most commonly prescribed generic drugs in Canada. This year?s study ...

10. The Misguided War Against Medicines 2010

    The Misguided War against Medicines 2010 examines all of the ways in which spending on drugs may contribute to the overall growth in total government health spending. The evidence suggests that neither patented medicines in particular, nor prescription ...